Localized differences in caudate and hippocampal shape are associated with schizophrenia but not antipsychotic type

Psychiatry Research - Neuroimaging

Volumn 211, Issue 1, 2013, Pages 1-10

  McClure, Robert K ^a   Styner, Martin ^a,b   Maltbie, Eric ^a   Lieberman, Jeffrey A ^d   Gouttard, Sylvain ^e   Gerig, Guido ^e   Shi, Xiaoyan ^c   Zhu, Hongtu ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c IL   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e UNIVERSITY OF UTAH   (United States)

Author keywords

Antipsychotic; Caudate; Hippocampus; Morphometry; MRI; Schizophrenia

Indexed keywords

HALOPERIDOL; OLANZAPINE;

ADULT; ARTICLE; BRAIN SIZE; CAUDATE NUCLEUS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; FEMALE; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CAUDATE NUCLEUS; DOUBLE-BLIND METHOD; FEMALE; HALOPERIDOL; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; ORGAN SIZE; SCHIZOPHRENIA;

EID: 84872852978     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2012.07.001     Document Type: Article

References (52)

1. Andersson C., Hamer R.M., Lawler C.P., Mailman R.B., Lieberman J.A. Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs. Neuropsychopharmacology 2002, 27(2):143-151.
2. Ballmaier M., Schlagenhauf F., Toga A.W., Gallinat J., Koslowski M., Zoli M., Hojatkashani C., Narr K.L., Heinz A. Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia. Schizophrenia Research 2008, 106(2-3):140-147.
3. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B: Methodological 1995, 57(1):289-300.
4. Callicott J.H., Mattay V.S., Verchinski B.A., Marenco S., Egan M.F., Weinberger D.R. Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. American Journal of Psychiatry 2003, 160(12):2209-2215.
5. Carracso J., Penkowa M., Hadberg H., Molinero A., Hidalgo J. Enhanced seizures and hippocampal neurodegeneration following kainic acid-induced seizure in metallothionein-I+II-deficient mice. European Journal of Neuroscience 2000, 12:2311-2322.
6. Chakos M., Lieberman J.A., Bilder R.M., Borenstein M., Lerner G., Bogerts B., Wu H., Kinon B., Manzar A. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. American Journal of Psychiatry 1994, 151:1430-1436.
7. Chakos M.H., Schobel S., Gu H., Gerig G., Bradford D., Charles C., Lieberman J. Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia. British Journal of Psychiatry 2005.
8. Corson P., Nopoulosa P., Andreasen N.C., Heckela D., Arndta S. Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network. Biological Psychiatry 1999, 46(5):712-720.
9. Corson P.W., Nopoulos P., Miller D.D., Arndt S., Andreason N.C. Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. American Journal of Psychiatry 1999, 156(8):1200-1204.
10. Csernansky J.G., Joshi S., Wang L., Haller J.W., Gado M., Miller J.P., Grenander U., Miller M.I. Hippocampal morphometry in schizophrenia by high dimensional brain mapping. Proceedings of the National Academy of Sciences of the United States of America 1998, 95(19):11406-11411.
11. Csernansky J.G., Wang L., Jones D., Rastogi-Cruz D., Posener J.A., Heydebrand G., Miller J.P., Miller M.I. American Journal of Psychiatry 2002, 159(12):2000-2006.
12. Davis K., Buchsbaum M.S., Shihabuddin L., Speigel-Cohen J., Metzger M., Frecska E., Keefe R.S., Powchick P. Ventricular enlargement in poor-outcome schizophrenia. Biological Psychiatry 1998, 43:783-793.
13. DeLisi L., Dauphinas I.D., Gershon E.S. Perinatal complications and reduced size of brain limbic structures in familial schizophrenia. Schizophrenia Bulletin 1988, 14:185-191.
14. DeLisi L., Sakuma M., Tew W., Kushner M., Hoff A.L., Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Research: Neuroimaging 1997, 74:129-140.
15. DeLisi L., Tew W., Xie S., Hoff A.L., Sakuma M., Kushner M., Lee G., Shedlack K., Smith A.M., Grimson R. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings. Biological Psychiatry 1995, 38:349-360.
16. DeLisi L.E., Stritzke P., Riordan H., Holan V., Boccio A., Kushner M., McClelland J., Van Eyl O., Anand A. The timing of brain morphological changes in schizophrenia and their relationship to clinical outcome. Biological Psychiatry 1992, 31(3):241-254.
17. Draganski B., Kherif F., Kloppel S., Alexander C., Parker G.J., Deichmann R., Ashburner J., Frackowiak R.S. Evidence for segregated and integrative connectivity patterns in the human Basal Ganglia. Journal of Neuroscience 2008, 28(28):7143-7152.
18. Fletcher P., Joshi S., Lu C., Pizer S. Gaussian distributions on Lie groups and their application to statistical shape analysis. Information Processing in Medical Imaging 2003, 18:450-462.
19. Garver D., Nair T.R., Chrisensen J.D., Holcomb J.A., Kingsbury S.L. Brain and ventricular instability during psychotic episodes of the schizophrenias. Schizophrenia Research 2000, 44:11-23.
20. Gorczowski K., Styner M., Jeong J.Y., Marron J.S., Piven J., Hazlett H.C., Pizer S.M., Gerig G. Multi-object analysis of volume, pose, and shape using statistical discrimination. IEEE Transactions on Pattern Analysis and Machine Intelligence 2010, 32(4):652-661.
21. Gouttard, S., Styner, M., Joshi, S., Gerig, G., 2007. Subcortical structure segmentation using probabilistic atlas prior. In: Proceedings of the SPIE Medical Imaging, vol. 65122, pp. J1-J11.
22. Gur R.E., Maany V., Mozley P.D., Swanson C., Bilker W., Gur R.C. Subcortical MRI volumes in neuroleptic naive and treated patients with schizophrenia. American Journal of Psychiatry 1998, 155:1711-1717.
23. Gur R., Cowell P., Turetsky B.I., Gallacher F., Cannon T., Bilker W., Gur R.C. A follow-up magnetic resonance imaging study of schizophrenia. Archives of General Psychiatry 1998, 55:145-152.
24. Han Q., Pizer S.M., Merck D., Joshi S., Jeong J.Y. Multi-figure anatomical objects for shape statistics. Information Processing in Medical Imaging 2005, 19:701-712.
25. Jacobsen L., Giedd J.N., Castellanos F.X., Vaituzis A.C., Hamburger S.D., Kumra S., Lenane M.C., Rapoport J.L. Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. American Journal of Psychiatry 1998, 155:678-685.
26. Keshavan M., Bagwell W.W., Haas G.L., Sweeney J.A., Schooler N.R., Pettegrew J.W. Changes in caudate volume with neuroleptic treatment. The Lancet 1994, 344:1434.
27. Keshavan M.S., Rosenberg D., Sweeney J.A., Pettegrew J.W. Decreased caudate volume in neuroleptic-naive psychotic patients. American Journal of Psychiatry 1998, 155(6):774-778.
28. Lee H., Tarazi F.I., Chakos M., Wu H., Redmond M., Alvir J.M., Kinon B.J., Bilder R., Creese I., Lieberman J.A. Effects of chronic treatment with typical and atypical antipsychotic drugs on the rat striatum. Life Sciences 1999, 64(18):1595-1602.
29. Levitt J.J., McCarley R.W., Dickey C.C., Voglmaier M.M., Niznikiewicz M.A., Seidman L.J., Hirayasu Y., Ciszewski A.A., Kikinis R., Jolesz F.A., Shenton M.E. MRI study of caudate nucleus volume and its cognitive correlates in neuroleptic-naive patients with schizotypal personality disorder. American Journal of Psychiatry 2002, 159(7):1190-1197.
30. Levitt J.J., Steiner M., Niethammer M., Sylvain B., Koo M.S., Voglmaier M.M., Dickey C.,C., Niznikiewicz M.A., Kikinis R., Robert W.M., Shenton M.E. Shape abnormalities of caudate nucleus in schizotypal personality disorder. Schizophrenia Research 2009, 110(1-3):127-139.
31. Liang K., Zeger S.L. Longitudinal data analysis using generalized linear models. Biometrika 1986, 73:13-22.
32. Lieberman J., Chakos M.A., Wu H., Alvir J., Hoffman E., Robinson D., Bilder R. Longitudinal study of brain morphology in first episode schizophrenia. Biological Psychiatry 2001, 49:487-499.
33. Lieberman J.A., Tollefson G.D., Charles C., Zipursky R., Sharma T., Kahn R.S., Keefe R.S.E., Green A.I., Gur R.E., McEvoy J., Perkins D., Hamer R.M., Gu H., Tohen M. Antipsychotic drug effects on brain morphology in first-episode psychosis. Archives of General Psychiatry 2005, 62(4):361-370. HGDH Study Group.
34. Mamah D., Harms M.P., Wang L., Barch D., Thompson P., Kim J., Miller M.I., Csernansky J.G. Basal ganglia shape abnormalities in the unaffected siblings of schizophrenia patients. Biological Psychiatry 2008, 64(2):111-120.
35. Mamah D., Wang L., Barch D., de Erausquin G.A., Gado M., Csernansky J.G. Structural analysis of the basal ganglia in schizophrenia. Schizophrenia Research 2007, 89(1-3):59-71.
36. Massana G., SalgadoPineda P., Junqué C., Pérez M., Baeza I., Pons A., Massana J., Navarro V., Blanch J., Morer A., Mercader J.M., Bernardo M. Volume changes in gray matter in first-episode neuroleptic-naive schizophrenic patients treated with risperidone. Journal of Clinical Psychopharmacology 2005, 25(2):111-117.
37. Mathalon D., Sullivan E.V., Lim K.O., Pfefferbaum A. Progressive brain volume changes and the clinical course of schizophrenia in men. Archives of General Psychiatry 2001, 58:148-157.
38. McClure R.K., Lieberman J.A. Neurodevelopmental and neurodegenerative hypothesise of schizophrenia: a review and critique. Current Opinion in Psychiatry 2003, 16(Suppl. 2):S15-S28.
39. McClure R.K., Weinberger D.R. The neurodevelopmental hypothesis of schizophrenia: a review of the evidence. Current Issues in the Psychopharmacology of Schizophrenia 2001, 27-56. Lippincott Williams and Wilkins Healthcare, Philadelphia. A. Breier, P.V. Tran, H.M. Herrea, G.D. Tollefson, F.P. Bymaster (Eds.).
40. Morey R., Mitchell T.V., Inan S., Lieberman J.A., Belger A. Neural correlates of automatic and controlled auditory processing in schizophrenia. Journal of Neuropsychiatry and Clinical Neurosciences 2008, 20(4):419-430.
41. Pizer S., Fletcher P.T., Joshi S., Gash A.G., Stough J., Thall A., Tracton G., Chaney E.L. A method and software for segmentation of anatomic object ensembles by deformable M-reps. Medical Physics 2005, 32(5):1335-1345.
42. Rapoport J.L., et al. Childhood-onset schizophrenia: progressive ventricular change during adolescence. Archives of General Psychiatry 1997, 54:897-903.
43. Shi X.Y., Ibrahim J.G., Styner M., Yimei L., Zhu H.T. Two-stage adjusted exponential tilted empirical likelihood for neuroimaging data. Annals of Applied Statistics 2011, 5:1132-1158.
44. Shihabuddin L., Buchsbaum M.S., Hazlett E.A., Haznedar M., Harvey P.D., Newman A., Schnur D.B., Spiegel-Cohen J., Tsechung W., Machac J., Knesaurek K., Vallabhajosula S., Biren M.A., Ciaravolo T.M., Luu-Hsia C. Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task. Archives of General Psychiatry 1998, 55:235-243.
45. Styner M., Gerig G., Lieberman J., Jones D., Weinberger D. Statistical shape analysis of neuroanatomical structures based on medial models. Medical Image Analysis 2003, 7(3):207-220.
46. Styner M., Lieberman J.A., McClure R.K., Weinberger D.R., Jones D.W., Gerig G. Morphometric analysis of lateral ventricles in schizophrenia and healthy controls regarding genetic and disease-specific factors. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(13):4872-4877.
47. Styner M., Lieberman J.A., Pantazis D., Gerig G. Boundary and medial shape analysis of the hippocampus in schizophrenia. Medical Image Analysis 2004, 8(3):197-203.
48. Szeszko P.R., Goldberg E., Gunduz-Bruce H., Ashtari M., Robinson D., Malhotra A.K., Lencz T., Bates J., Crandall D.T., Kane J.M., Bilder R.M. Smaller anterior hippocampal formation volume in antipsychotic-naive patients with first-episode schizophrenia. American Journal of Psychiatry 2003, 160(12):2190-2197.
49. Tauscher-Wisniewski S., Tauscher J., Logan J., Christensen B.K., Mikulis D.J., Zipursky R.B. Caudate volume changes in first episode psychosis parallel the effects of normal aging: a 5-year follow-up study. Schizophrenia research 2002, 58(2-3):185-188.
50. Velakoulis D., et al. Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study. Archives of General Psychiatry 1999, 56(2):133-141.
51. Weinberger D.R., McClure R.K. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain?. Archives of General Psychiatry 2002, 59(6):553-558.
52. Zhu H., Zhou H., Chen J., Li Y., Lieberman J., Styner M. Adjusted exponentially tilted likelihood with applications to brain morphology. Biometrics 2009, 65:919-927.